aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.350
+0.200 (6.35%)
At close: Dec 20, 2024, 4:00 PM
3.390
+0.040 (1.19%)
After-hours: Dec 20, 2024, 7:41 PM EST
aTyr Pharma Employees
As of December 31, 2023, aTyr Pharma had 59 total employees, including 56 full-time and 3 part-time employees. The number of employees decreased by 11 or -15.71% compared to the previous year.
Employees
59
Change (1Y)
-11
Growth (1Y)
-15.71%
Revenue / Employee
$3,983
Profits / Employee
-$1,081,627
Market Cap
281.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Canopy Growth | 1,029 |
Amylyx Pharmaceuticals | 384 |
Vanda Pharmaceuticals | 203 |
C4 Therapeutics | 145 |
Foghorn Therapeutics | 116 |
Candel Therapeutics | 42 |
DiaMedica Therapeutics | 19 |
ATYR News
- 9 days ago - aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors - GlobeNewsWire
- 12 days ago - aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis - GlobeNewsWire
- 5 weeks ago - aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis - GlobeNewsWire
- 2 months ago - aTyr Pharma: The Bull Has Finally Come Out - Seeking Alpha
- 2 months ago - aTyr Pharma to Present at the LD Micro Main Event XVII in October - Newsfile Corp
- 3 months ago - aTyr Pharma: Two 2025 Data Readouts Could Provide Inflection Point - Seeking Alpha
- 4 months ago - aTyr Pharma to Participate in September Investor Conferences - GlobeNewsWire
- 4 months ago - aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update - GlobeNewsWire